Recipharm, a Jordbro, Sweden-headquartered contract development and manufacturing organization, has opened a newly built GMP suite for clinical trial material manufacture at its facility in Research Triangle Park, North Carolina.

The suite, which represents a $750,000 investment and is ISO 8 certified, is intended to produce clinical-trial material for clinical studies up to Phase II for non-sterile dosage forms, including metered dose inhalers and semi-solid topical products. It has the capacity to produce metered dose inhalers in up to 25-liter batches and offers semi-solid production capabilities up to 20 liters.

Source: Recipharm